(china) Iv L.p. Pontifax
10% Owner at Keros Therapeutics, Inc. (KROS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $85.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 17SEC | KROSKeros Therapeutics, Inc. | Sell | 2,284,612 | $17.75 | $40.6M | -32.7% |
| Oct 17SEC | KROSKeros Therapeutics, Inc. | Sell | 1,121,045 | $17.75 | $19.9M | -32.7% |
| Oct 17SEC | KROSKeros Therapeutics, Inc. | Sell | 1,226,412 | $17.75 | $21.8M | -32.7% |
| Oct 17SEC | KROSKeros Therapeutics, Inc. | Sell | 155,262 | $17.75 | $2.8M | -32.7% |